Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Underexposed Canadian Stocks -- Ignore unavailable to you. Want to Upgrade?

To: Underexposed who wrote (50)

6/23/2018 2:01:08 PM

From: Underexposed

Read Replies (1) | Respond to of 65

Portfolio update June 22/18 - another nice gain of 1% plus new stocks added

Slow and steady is the way to go IMHO. I would be totally happy with a 0.5% gain per week :)

Here is the chart for the portfolio

Current Portfolio as of June 22, 2018

Ticker	Company	Shares	Price	Value	% Gain/loss	Dividends

DRG/UN.TO	Dream Global REIT	1000	$14.53	$14,530.00	13.96%	$500.03
ADW/A.TO	Andrew Peller Ltd. Class A	2000	$17.99	$35,980.00	1.07%	$180.00
CF.TO	Canaccord Financial Inc.	5000	$7.25	$36,250.00	5.84%	$50.00
TLT.V	Theralase Technologies Inc	9250	$0.380	$3,515.00	-6.17%	$0.00
CWX.TO	Canwel Holdings Inc	1500	$7.34	$11,010.00	2.23%	$0.00
AI.TO	Atrium Mortgage Investment	850	$12.93	$10,990.50	-0.15%	$0.00

			Totals	$112,275.50		$730.03

			Dividends added to available cash
			%Gain/Loss based on Value only...no dividends
ORDERS
	June 18/18: Limit buy of 1500 shares of Canwell Holdings Inc @ $7.18/share					Done June 18/18
	June 18/18: Limit buy of 850 shares of Atrium Mortgage Investment @ $12.95/share Done June 18/18

Underexposed Canadian Fantasy Portfolio Value

Initial:	$100,000.00
Cash :	$656.25

Date	Value	%Gain/Loss
15-Dec	$100,000.00
22-Dec	$99,900.00	-0.1%
29-Dec	$104,680.00	4.7%
5-Jan	$107,615.00	7.6%
12-Jan	$106,765.00	6.8%
19-Jan	$112,170.00	12.2%
26-Jan	$107,160.00	7.2%
2-Feb	$106,065.00	6.1%
9-Feb	$104,505.00	4.5%
8-Jun	$110,355.00	10.4%
15-Jun	$111,913.75	11.9%
22-Jun	$112,931.75	12.9%

Conclusion

Canaccord continues to perform well and we had a nice bounce from Theralase.Theralase is really a long term hold. It will be entering Phase II of its trials soon and there is high hopes for this stock given its performance in their Phase I trial.

This should be a stable portfolio in content for a while. Check out Breakwater BRE.TO.... another choice has taken off as well but I was limited in funds in this portfolio... though I did make a purchase in my real portfoilio.

Good Trading
UE